Parallax Volatility Advisers
CRMD icon

Parallax Volatility Advisers’s CorMedix CRMD Stock Holding History

Parallax Volatility Advisers’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-84,461
Closed -$684K – 1662
2024
Q4 		$684K Buy
84,461
+4,318
+5% +$43.1K ﹤0.01% 1440
2024
Q3 		$648K Buy
+80,143
New +$434K ﹤0.01% 1464

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Parallax Volatility Advisers's CRMD Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of CorMedix (CRMD) in Q1 2025, closing a stake of 84,461 shares — an estimated $684K sold.

Parallax Volatility Advisers first reported a position in CRMD in Q3 2024 and held it in 2 quarters. The position peaked at $684K in Q4 2024. 137 funds tracked by Wall St. Rank hold CRMD as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining CorMedix position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 84,461 CorMedix shares in Q1 2025, an estimated $684K.
  • Parallax Volatility Advisers first reported a position in CorMedix in Q3 2024 and held it in 2 quarters.
  • Parallax Volatility Advisers's CorMedix position peaked at $684K in Q4 2024.
  • 137 funds tracked by Wall St. Rank held CorMedix as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.